Wake Up With Breakfast News!

Wake up to the latest market news, company insights, and a bit of Foolish fun -- all wrapped up in one quick, easy-to-read email, called Breakfast News. Delivered at 7:30 a.m. ET every single market day. See an example of our weekday Breakfast News email & sign-up below.

Loading image...

Market Data Table

Breakfast News: Alphabet Goes Shopping for Data

August 18, 2026

Monday's Markets
S&P 500 7,745 (-0.52%)
Nasdaq 26,645 (-0.32%)
Dow 53,460 (-0.51%)
Bitcoin $64,222 (+1.83)

Loading raw_html...

1) Alphabet's $10 Million Shortcut to Real-World AI Data

Chart tracking Alphabet's cash and cash equivalents over the past three years, falling slightly from about $31 billion in Q3 2023 to around $20 billion in Q4 2024 and hovering in the low-$20 billions until Q3 2025 before slowly rising to $56 billion in Q2 2026.

Loading raw_html...

Alphabet (NASDAQ:GOOG) won a bankruptcy auction for the wreckage of collapsed budget carrier Spirit Aviation Holdings. It's paying $10 million for a trove of business data to feed into its artificial intelligence (AI) models: 100 million emails, 500 million Microsoft Teams messages, 30 million lines of code, and 175,000 employee records dating back to 1986.

Real corporate data is scarce: $10 million barely registers against Alphabet's balance sheet. What it buys matters more, in this case, years of real enterprise emails, code, and internal chatter. It's the kind of labeled, real-world data that's far harder to find than public web text. Buying a bankrupt company's digital estate is now a cheap way to get it.
Expect more deals like this and eventually tighter rules on them: Distressed companies are sitting on troves like Spirit's, and AI labs need the fuel. More bankruptcy-driven data buys are coming across industries, and regulators and privacy advocates will eventually push back once someone's old emails end up training a chatbot. That fight would raise the cost of these deals. It wouldn't end them: Employee and customer data is too valuable for AI labs to walk away from.

Loading paragraph...

2) Tesla's Self-Driving Promise Close to Hitting the Street

The Information reports Tesla (NASDAQ:TSLA) is telling employees to prepare for a public launch of its driverless Cybercab in Austin as soon as this month. Employees would ride first on public roads. Tesla would then fold the cars into its existing Austin robotaxi service days later. Tesla didn't deny the report. It launched a lottery for rides at an event tied to the same timeline right after the story broke.

Years of promises meet reality: Elon Musk has said Tesla would solve self-driving "this year" for several years running. Unsupervised rides in a car with no steering wheel would be the clearest proof yet that this is finally the year the promise holds.
The business model shifts with it: Last week, Fool contributing analyst Lou Whiteman discussed the company with TMF co-founder and CEO Tom Gardner. They said, "The progressive commercialization of Full Self-Driving (FSD) and driverless ride-hailing networks shifts Tesla's financial model from capital-intensive manufacturing to asset-light, high-margin software licensing and platform fees." As a result, "Tesla is well-positioned to be a net beneficiary of the AI revolution rather than a victim."

Loading paragraph...

3) Rising Yields and Oil Prices Hit Nasdaq Futures

Nasdaq futures fell close to 1% in pre-market trading as U.S. Treasury yields climbed and the U.S.-Iran ceasefire expired. Tehran is threatening a more aggressive military posture, pushing Brent crude above $90 a barrel. The 30-year Treasury yield topped 5.3%, its highest level in almost two decades, and the 10-year approached 4.74%.

Rate-sensitive tech takes the hit: Higher oil raises inflation risk and the odds of tighter financial conditions, a bad combination for expensive technology stocks. Growth stocks price in profits years out, so when long-term rates rise, those future profits are worth less today. That's why the Nasdaq, not the Dow, is leading the futures decline.
The AI thesis isn't broken by a rate move: Nothing here changes what AI companies are actually building or spending. Watch adoption and capital expenditure (capex) data for the real test of the thesis, not a futures dip driven by an overnight headline. A one-day move like this isn't a reason to sell AI winners.

Loading paragraph...

4) Meta's Child-Safety Reckoning Continues

Meta Platforms (NASDAQ:META) heads to trial today in Oakland, where California and a coalition of 29 states will argue the company built Facebook and Instagram to be addictive to kids. Meta already lost a similar fight in New Mexico this month. It was ordered to pay $942 million combined between a jury verdict and a child-safety abatement fund. States now want as much as $200 billion from Meta nationwide; Meta's own lawyers have floated a worst-case number near $1.4 trillion.

The math behind the risk: Meta pulls 98% of its revenue from advertising, the same engine funding Mark Zuckerberg's roughly $145 billion AI infrastructure spend this year. States want it to strip out infinite scroll, autoplay, and engagement-optimized algorithms nationwide, changes that would hit the recommendation engine behind that same ad targeting.
Watch the verdict, not the opening bell: The trial's start date changes nothing for a long-term holder. What would change it is a ruling that forces Meta to gut the algorithms driving engagement, since those algorithms are also what make its ad targeting valuable. Until there's a verdict with real remedies attached, this is a legal cloud on the stock, not a reason to sell it.

Loading paragraph...

5) TransMedics Delivers

Few stocks have tested our conviction like TransMedics (NASDAQ:TMDX). In the last two years, a short report and concerns about growth have halved the stock from the $160s to the high $80s. Yet Team Hidden Gems and Team Rule Breakers have recommended the founder-led company more than 30 times since 2019. Today, it trades near $88 -- up nearly 280% since our first recommendation.

TransMedics cracked a decades-old medical problem. Its Organ Care System keeps donor hearts, livers, and lungs warm and functioning outside the body, so more survive the trip to patients.

A moat with wings: TransMedics flies donor organs on its own fleet of 22 aircraft and now handles 86% of missions in-house. That vertical integration widens with every new route added.
Spending to win: Revenue hit a record $190 million last quarter, up 21%. Management raised the low end of its full-year guidance. TransMedics is pouring that money into aircraft, a European hub, and a kidney program. It's pinching margins now to ultimately widen the moat.

Team Hidden Gems has a 5-year price prediction of $268.88.

Team Rule Breakers has a midpoint 5-year price prediction of $141.50.

HG targets over 20% per year. RB targets 10% per year. And Fidelity owns a whopping 15% of the company.

Loading paragraph...

6) Your Take

If your portfolio comprised just Home Depot (NYSE:HD), Target (NYSE:TGT), and TJX Companies (NYSE:TJX) and you bought each of them at the start of the year with the same amount of money and had to buy more shares in one, completely close your position in another, and hold the final stock, what are you choosing to do and why?

Debate with friends and family, or become a member to hear what your fellow Fools are saying!

Loading paragraph...